Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients

Ran Huo(Nanjing Medical University), Shengying Qin(Shanghai Jiao Tong University), Donghong Cui(Shanghai Jiao Tong University), Jiajun Shi(National University of Singapore), Wenqiang Li(Henan Provincial Institute of Occupational Health), Yichen Liu(Shanghai Jiao Tong University), Qinghe Xing(Children's Hospital of Fudan University), Jie Jiang(Shanghai Institutes for Biological Sciences), Lin He(Shanghai Institutes for Biological Sciences), Yucai Yan(Shanghai Institutes for Biological Sciences), Yuyu Xiong(Henan University of Technology), Zhiyun Wei(Brigham and Women's Hospital)
Neuroscience Letters
August 29, 2014
10.1016/j.neulet.2014.08.041
Cited by 16

Related Papers

Cytochrome P450 Enzymes and Drug Metabolism in Humans
|International Journal of Molecular Sciences|2021|939
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
|Nature Communications|2017|549
Does green finance investment impact on sustainable development: Role of technological innovation and renewable energy
|Renewable Energy|2023|160
MiR-140 is co-expressed with<i>Wwp2-C</i>transcript and activated by Sox9 to target<i>Sp1</i>in maintaining the chondrocyte proliferation
|FEBS Letters|2011|142